HomeClassifiedsHealthMedical Products & ServicesLenalidomide and Rituximab combination for Treatment of MCL
Lenalidomide and Rituximab combination for Treatment of MCL
Description
MCL is mantle cell lymphoma is an incurable disease. Lenalidomide and rituximab combination for the treatment of MCL is an immunomodulatory regimen that has shown positive activity in patients with indolent B-cell non-Hodgkin’s lymphoma. Lenalidomide and rituximab combination is useful for treating patients who have relapsed /refractory MCL. The patients who are progressive on this combinational treatment responded in favour of the subsequent therapeutic regimens.
Recent Classifieds
PPC Ads - Google Ads & Meta Ads Coimbatore
Coimbatore
Boost Brand Reach with LED Van Advertising in Kolkata | Sign Service
Kolkata, West Bengal, India
Best Super Speciality Hospital in Patancheru
Hyderabad, India
Reliable Building and Pest Inspections in Melbourne
Clyde North, Victoria, Australia
Math Assignment Help
34 Matilda Ave, Wantirna south, Vic 3125, Melbourne, Australia
Alkademy Press
Related Classifieds
Access prescription for medication with online pharmacy app
Mississauga, ON
Autoclave and Sterilizers Machines Exporter in India
Desco House, 387 F.I.E, Patpar Ganj Industrial Area New Delhi 110092
Shoe Cover Online | Coronavirus Protection Gears | PPE
₹105
Ghaziabad, Uttar Pradesh, India
AGEMAX DHA POWDER
₹198
Jabalpur, Madhya Pradesh, India
Best homeopathy doctor in india
Jaipur, Rajasthan, India
Want monopoly rights for a PCD Pharma Franchise in Mumbai?
₹0
SCO 36, Sector 3, Panchkula, 134109 Haryana